Cision PR Newswire, Author at World Lifestyler

No Result

View All Result

WORLD LIFESTYLER

No Result

View All Result

Home Author

Cision PR Newswire

Press Releases - Lifestyle

MICROIP to Debut “AI Vehicle System Business Group” and Edge AI Innovations at COMPUTEX 2026

June 1, 2026

Press Releases - Lifestyle

ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept

June 1, 2026

Press Releases - Lifestyle

Long-term Follow-up Results of CARsgen’s Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting

June 1, 2026

Press Releases - Lifestyle

Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)

June 1, 2026

Press Releases - Lifestyle

MARSTEK Unveils the New VENUS Family, Expanding Plug-in Batteries into a New Era of Home Energy Storage

May 31, 2026

Press Releases - Lifestyle

Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders

May 31, 2026

Press Releases - Lifestyle

Cook County Treasurer Maria Pappas’ Historic Property Tax Sale Reform Legislation Passes in Illinois General Assembly

May 31, 2026

Press Releases - Lifestyle

SIX FLAGS FIESTA TEXAS UNLEASHES WEREWOLF GORGE, THE WORLD’S LONGEST FAMILY LAUNCH ROLLER COASTER

May 31, 2026

Press Releases - Lifestyle

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

May 31, 2026

Press Releases - Lifestyle

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

May 31, 2026

Page 1358 of 4155 Prev 1 … 1,357 1,358 1,359 … 4,155 Next

No Result

View All Result

Home

Cision PR Newswire

MICROIP to Debut “AI Vehicle System Business Group” and Edge AI Innovations at COMPUTEX 2026

ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept

Long-term Follow-up Results of CARsgen’s Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting

Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)

MARSTEK Unveils the New VENUS Family, Expanding Plug-in Batteries into a New Era of Home Energy Storage

Golden Goblet Competition Lineup Announced: Spotlight on the 2026 Contenders

Cook County Treasurer Maria Pappas’ Historic Property Tax Sale Reform Legislation Passes in Illinois General Assembly

SIX FLAGS FIESTA TEXAS UNLEASHES WEREWOLF GORGE, THE WORLD’S LONGEST FAMILY LAUNCH ROLLER COASTER

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

Recommended

Pam Harrington Exclusives Adds Real Estate Veteran Jenny Bernard to Its Kiawah Island Team of Specialists

Founder-Led E-Commerce Distributor FactoryMation Partners with MD Holdings to Accelerate Strategic Growth

Popular News

Clideo Announces Comprehensive Framework for Modern PR and Multimedia Repurposing

Adhesive Tapes Market worth $117.47 billion by 2031 – Exclusive Report by MarketsandMarkets™

Marquis Who’s Who Honors Logan Noblin, Esq., as a Top Professional

UTulsa now the most affordable private research university in America’s heartland

BODY20 Expands EMS Beyond Strength Training with New 20-Minute Tone Class

Connect with us

About & Contact

Explore Content

Legal & Privacy

Tiny Media Brands